Sign inGet started

[AAVL]

Avalanche Biotechnologies, Inc.CIK 1501756 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
7

AI insights for [AAVL] PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for [AAVL]
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Schwartz Steven DanielDirector3$0$1.30M2015-06-15
Gasmi MehdiVP, Pharmaceutical Development14$0$75.9K2015-06-15
Wachter PaulDirector13$0$262.7K2015-06-15
Bain LindaChief Financial Officer9$0$174.7K2015-06-12
Blumenkranz Mark S.Director10$0$1.99M2015-06-11
Chalberg Thomas W.Chief Executive Officer3$0$951.2K2015-06-10
Hull HansSVP, Business Operations3$0$75.3K2015-06-04

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Gasmi MehdiSVP,Pharmaceutical Developme M Exercise deriv2015-06-152015-06-17500— $095,000SEC↗
Schwartz Steven DanielDirector S Sale2015-06-152015-06-1716,875$39.86 $672.6K367,931SEC↗
Wachter PaulDirector S Sale2015-06-152015-06-171,192$39.86 $47.5K37,161SEC↗
Gasmi MehdiSVP,Pharmaceutical Developme S Sale2015-06-152015-06-17500$39.86 $19.9K7,000SEC↗
Gasmi MehdiSVP,Pharmaceutical Developme M Exercise2015-06-152015-06-17500$2.75 $1.4K7,500SEC↗
Bain LindaChief Financial Officer M Exercise deriv2015-06-122015-06-153,500— $0233,000SEC↗
Bain LindaChief Financial Officer S Sale2015-06-122015-06-153,500$39.94 $139.8K9,000SEC↗
Bain LindaChief Financial Officer M Exercise2015-06-122015-06-153,500$3.15 $11.0K12,500SEC↗
Blumenkranz Mark S.Director S Sale2015-06-112015-06-151,900$39.97 $75.9K522,989SEC↗
Chalberg Thomas W.Chief Executive Officer S Sale2015-06-102015-06-116,995$38.90 $272.1K258,988SEC↗
Chalberg Thomas W.Chief Executive Officer S Sale2015-06-102015-06-115,035$36.89 $185.7K278,953SEC↗
Chalberg Thomas W.Chief Executive Officer S Sale2015-06-102015-06-1112,970$38.04 $493.4K265,983SEC↗
Blumenkranz Mark S.Director S Sale2015-06-102015-06-11600$39.91 $23.9K524,889SEC↗
Blumenkranz Mark S.Director S Sale2015-06-092015-06-1115,300$35.52 $543.5K532,689SEC↗
Blumenkranz Mark S.Director S Sale2015-06-092015-06-117,000$36.20 $253.4K525,689SEC↗
Blumenkranz Mark S.Director S Sale2015-06-092015-06-11200$37.35 $7.5K525,489SEC↗
Gasmi MehdiVP, Pharmaceutical Developme M Exercise deriv2015-06-082015-06-10500— $095,500SEC↗
Gasmi MehdiVP, Pharmaceutical Developme M Exercise2015-06-082015-06-10500$2.75 $1.4K7,500SEC↗
Gasmi MehdiVP, Pharmaceutical Developme S Sale2015-06-082015-06-1082$39.88 $3.3K7,000SEC↗
Gasmi MehdiVP, Pharmaceutical Developme S Sale2015-06-082015-06-10183$38.95 $7.1K7,082SEC↗
Gasmi MehdiVP, Pharmaceutical Developme S Sale2015-06-082015-06-10235$37.97 $8.9K7,265SEC↗
Wachter PaulDirector S Sale2015-06-082015-06-10475$38.96 $18.5K38,529SEC↗
Wachter PaulDirector S Sale2015-06-082015-06-10541$37.96 $20.5K39,004SEC↗
Wachter PaulDirector S Sale2015-06-082015-06-10176$39.88 $7.0K38,353SEC↗
Blumenkranz Mark S.Director S Sale2015-06-052015-06-085,000$40.08 $200.4K547,989SEC↗
Hull HansSVP, Business Operations M Exercise deriv2015-06-042015-06-052,000— $020,500SEC↗
Hull HansSVP, Business Operations M Exercise2015-06-042015-06-052,000$0.19 $38013,320SEC↗
Hull HansSVP, Business Operations S Sale2015-06-042015-06-052,000$37.64 $75.3K11,320SEC↗
Schwartz Steven DanielDirector S Sale2015-06-012015-06-0214,157$36.11 $511.2K387,899SEC↗
Schwartz Steven DanielDirector S Sale2015-06-012015-06-023,093$36.81 $113.9K384,806SEC↗
Wachter PaulDirector S Sale2015-06-012015-06-02210$36.81 $7.7K39,545SEC↗
Wachter PaulDirector S Sale2015-06-012015-06-02982$36.11 $35.5K39,755SEC↗
Gasmi MehdiVP, Pharmaceutical Developme M Exercise deriv2015-05-282015-05-29500— $096,000SEC↗
Gasmi MehdiVP, Pharmaceutical Developme S Sale2015-05-282015-05-29500$38.02 $19.0K7,000SEC↗
Gasmi MehdiVP, Pharmaceutical Developme M Exercise2015-05-282015-05-29500$2.75 $1.4K7,500SEC↗
Wachter PaulDirector S Sale2015-05-262015-05-27786$36.52 $28.7K41,143SEC↗
Wachter PaulDirector S Sale2015-05-262015-05-27304$37.59 $11.4K40,839SEC↗
Wachter PaulDirector S Sale2015-05-262015-05-27102$38.30 $3.9K40,737SEC↗
Wachter PaulDirector S Sale2015-05-182015-05-191,192$35.31 $42.1K41,929SEC↗
Blumenkranz Mark S.Director S Sale2015-05-152015-05-184,525$36.00 $162.9K552,989SEC↗
Blumenkranz Mark S.Director S Sale2015-05-152015-05-1817,975$35.36 $635.6K557,514SEC↗
Gasmi MehdiVP, Pharmaceutical Developme M Exercise deriv2015-05-142015-05-15500— $097,000SEC↗
Gasmi MehdiVP, Pharmaceutical Developme M Exercise2015-05-142015-05-15500$2.75 $1.4K7,500SEC↗
Gasmi MehdiVP, Pharmaceutical Developme S Sale2015-05-142015-05-15500$35.31 $17.7K7,000SEC↗
Bain LindaChief Financial Officer M Exercise deriv2015-05-132015-05-13285— $0236,500SEC↗
Bain LindaChief Financial Officer S Sale2015-05-132015-05-13285$34.94 $10.0K9,000SEC↗
Bain LindaChief Financial Officer M Exercise2015-05-132015-05-13285$3.15 $8989,285SEC↗
Blumenkranz Mark S.Director S Sale2015-05-132015-05-13715$34.94 $25.0K575,489SEC↗
Bain LindaChief Financial Officer M Exercise deriv2015-05-112015-05-12715— $0236,785SEC↗
Blumenkranz Mark S.Director S Sale2015-05-112015-05-121,785$34.91 $62.3K576,204SEC↗
Bain LindaChief Financial Officer S Sale2015-05-112015-05-12715$34.91 $25.0K9,000SEC↗
Bain LindaChief Financial Officer M Exercise2015-05-112015-05-12715$3.15 $2.3K9,715SEC↗
Wachter PaulDirector S Sale2015-05-112015-05-12552$33.70 $18.6K43,253SEC↗
Wachter PaulDirector S Sale2015-05-112015-05-12132$34.29 $4.5K43,121SEC↗
Wachter PaulDirector S Sale2015-05-112015-05-12508$32.80 $16.7K43,805SEC↗